sphingosylphosphorylcholine

sphingosylphosphorylcholine is a lipid of Sphingolipids (SP) class. Sphingosylphosphorylcholine is associated with abnormalities such as Cerebral Vasospasm, Subarachnoid Hemorrhage, Atherosclerosis, Hypertensive disease and Niemann-Pick Diseases. The involved functions are known as MAP kinase kinase activity, JUN kinase activity, Phosphorylation, biphenyl synthase activity and Cell Death. Sphingosylphosphorylcholine often locates in Adipose tissue, Protoplasm, Body tissue, Membrane and Extracellular. The associated genes with sphingosylphosphorylcholine are UCN3 gene, MAPK9 gene, JUN gene, NAA50 gene and P4HTM gene. The related lipids are Lysophospholipids, lysophosphatidic acid, Lysophosphatidylcholines, Sphingolipids and Saponin. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of sphingosylphosphorylcholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with sphingosylphosphorylcholine?

sphingosylphosphorylcholine is suspected in Atherosclerosis, Niemann-Pick Diseases, Hypercholesterolemia, Dermatitis, Atopic, Chronic eczema, Cerebral Vasospasm and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with sphingosylphosphorylcholine

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type A D052536 1 associated lipids
Niemann-Pick Disease, Type B D052537 1 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Endotoxemia D019446 27 associated lipids
Insulinoma D007340 28 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Seizures D012640 87 associated lipids
Total 8

PubChem Associated disorders and diseases

What pathways are associated with sphingosylphosphorylcholine

Lipid pathways are not clear in current pathway databases. We organized associated pathways with sphingosylphosphorylcholine through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with sphingosylphosphorylcholine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with sphingosylphosphorylcholine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with sphingosylphosphorylcholine?

Mouse Model

Mouse Model are used in the study 'Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes.' (Sekiguchi K et al., 1999).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with sphingosylphosphorylcholine

Download all related citations
Per page 10 20 50 100 | Total 248
Authors Title Published Journal PubMed Link
Rodriguez-Lafrasse C and Vanier MT Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. 1999 Neurochem. Res. pmid:9972865
Orlati S et al. Sphingosylphosphorylcholine and sphingosine-1-phosphate mobilize cytosolic calcium through different mechanisms in human airway epithelial cells. 1998 Cell Calcium pmid:9924630
Imokawa G et al. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. 1999 J. Invest. Dermatol. pmid:9886270
Chen PF et al. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells. 1998 Kidney Int. pmid:9844123
Chin TY and Chueh SH Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway. 1998 Am. J. Physiol. pmid:9814974
Okamoto H et al. EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. 1998 J. Biol. Chem. pmid:9765227
Orlati S et al. Intracellular calcium mobilization and phospholipid degradation in sphingosylphosphorylcholine-stimulated human airway epithelial cells. 1998 Biochem. J. pmid:9729473
Meyer zu Heringdorf D et al. Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine. 1998 Eur. J. Pharmacol. pmid:9726638
Rodríguez-Fernández JL and Rozengurt E Bombesin, vasopressin, lysophosphatidic acid, and sphingosylphosphorylcholine induce focal adhesion kinase activation in intact Swiss 3T3 cells. 1998 J. Biol. Chem. pmid:9668122
Himmel HM et al. Guanine nucleotide-sensitive inhibition of L-type Ca2+ current by lysosphingolipids in RINm5F insulinoma cells. 1998 Mol. Pharmacol. pmid:9584212
Berger A et al. The potent lipid mitogen sphingosylphosphocholine activates the DNA binding activity of upstream stimulating factor (USF), a basic helix-loop-helix-zipper protein. 1998 Biochim. Biophys. Acta pmid:9507145
Wakita H et al. Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9506444
Rozengurt E and Rodríguez-Fernández JL Tyrosine phosphorylation in the action of neuropeptides and growth factors. 1997 Essays Biochem. pmid:9493012
Wiktorek-Wójcik M et al. Serine base exchange enzyme activity is modulated by sphingosine and other amphiphilic compounds: possible role of positive charge in increasing the synthesis of phosphatidylserine. 1997 Biochem. Biophys. Res. Commun. pmid:9405236
Törnquist K et al. Sphingosylphosphorylcholine activates an amiloride-insensitive Na+-H+-exchange mechanism in GH4C1 cells. 1997 Eur. J. Biochem. pmid:9346294
Sueyoshi N et al. Preparation of a naturally occurring D-erythro-(2S, 3R)-sphingosylphosphocholine using Shewanella alga NS-589. 1997 J. Lipid Res. pmid:9323602
Orlati S et al. Pertussis toxin- and PMA-insensitive calcium mobilization by sphingosine in CFPAC-1 cells: evidence for a phosphatidic acid-dependent mechanism. 1997 Biochim. Biophys. Acta pmid:9296526
Lai TS et al. Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase. 1997 J. Biol. Chem. pmid:9195933
Betto R et al. Sphingosylphosphocholine modulates the ryanodine receptor/calcium-release channel of cardiac sarcoplasmic reticulum membranes. 1997 Biochem. J. pmid:9078280
Furuya S et al. Lysosphingomyelin-elicited Ca2+ mobilization from rat brain microsomes. 1996 J Lipid Mediat Cell Signal pmid:8906576
Bünemann M et al. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. 1996 EMBO J. pmid:8896446
Spangelo BL and Jarvis WD Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. 1996 Endocrinology pmid:8828503
Berger A et al. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity. 1996 Mol. Pharmacol. pmid:8794881
Yasui K and Palade P Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes. 1996 Am. J. Physiol. pmid:8779930
Huang WC and Chueh SH Calcium mobilization from the intracellular mitochondrial and nonmitochondrial stores of the rat cerebellum. 1996 Brain Res. pmid:8773778
Mallampalli RK et al. Betamethasone modulation of sphingomyelin hydrolysis up-regulates CTP:cholinephosphate cytidylyltransferase activity in adult rat lung. 1996 Biochem. J. pmid:8761490
Murata Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? 1996 J. Invest. Dermatol. pmid:8752664
Van Koppen CJ et al. A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils. 1996 Mol. Pharmacol. pmid:8649355
Zanglis A et al. The biological activity of acetylated sphingosylphosphorylcholine derivatives. 1996 Int. J. Biochem. Cell Biol. pmid:8624845
Sun L et al. A new wound healing agent--sphingosylphosphorylcholine. 1996 J. Invest. Dermatol. pmid:8601721
Ohno K [Niemann-Pick disease types A and B]. 1995 Nippon Rinsho pmid:8577051
Sugiyama E et al. Metabolism and neurite promoting effect of exogenous sphingosylphosphocholine in cultured murine neuroblastoma cells. 1993 J. Biochem. pmid:8514735
Desai NN et al. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. 1993 J. Cell Biol. pmid:8389770
Wong K and Kwan-Yeung L Sphingosine mobilizes intracellular calcium in human neutrophils. 1993 Cell Calcium pmid:8358772
Törnquist K and Ekokoski E Effect of sphingosine derivatives on calcium fluxes in thyroid FRTL-5 cells. 1994 Biochem. J. pmid:8166643
Pushkareva MYu YA and Hannun Modulation of cytosolic protein phosphorylation by sphingosylphosphorylcholine. 1994 Biochim. Biophys. Acta pmid:8130276
Kim S et al. Sphingolipid-gated Ca2+ release from intracellular stores of endothelial cells is mediated by a novel Ca(2+)-permeable channel. 1995 J. Biol. Chem. pmid:7890637
Xu Y et al. Effect of lysophospholipids on signaling in the human Jurkat T cell line. 1995 J. Cell. Physiol. pmid:7775587
Dettbarn C et al. Involvement of ryanodine receptors in sphingosylphosphorylcholine-induced calcium release from brain microsomes. 1995 Brain Res. pmid:7712168
Liu R et al. Effects of sphingosine derivatives on MC3T3-E1 pre-osteoblasts: psychosine elicits release of calcium from intracellualr stores. 1995 Biochem. Biophys. Res. Commun. pmid:7677781
Berger A et al. Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7597047
Okajima F and Kondo Y Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. 1995 J. Biol. Chem. pmid:7592844
Seufferlein T and Rozengurt E Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway. 1995 J. Biol. Chem. pmid:7592646
Seufferlein T and Rozengurt E Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. 1995 J. Biol. Chem. pmid:7592645
Bitar KN and Yamada H Modulation of smooth muscle contraction by sphingosylphosphorylcholine. 1995 Am. J. Physiol. pmid:7573447
Hara A and Taketomi T Detection of D-erythro and L-threo sphingosine bases in preparative sphingosylphosphorylcholine and its N-acylated derivatives and some evidence of their different chemical configurations. 1983 J. Biochem. pmid:6654881
Callahan JW et al. Studies on the hydrophobic properties of sphingomyelinase. 1981 Biochem. J. pmid:6272705
Sripada PK et al. Partial synthesis and properties of a series of N-acyl sphingomyelins. 1987 J. Lipid Res. pmid:3611973
Strasberg PM and Callahan JW Lysosphingolipids and mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine. 1988 Biochem. Cell Biol. pmid:2977568
Baek S et al. DJ-1 Regulates Differentiation of Human Mesenchymal Stem Cells into Smooth Muscle-like Cells in Response to Sphingosylphosphorylcholine. 2017 Proteomics pmid:28949093
Kuchar L et al. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases. 2017 Anal. Biochem. pmid:28259515
Kim HJ et al. Novel involvement of RhebL1 in sphingosylphosphorylcholine-induced keratin phosphorylation and reorganization: Binding to and activation of AKT1. 2017 Oncotarget pmid:28209923
Kemppainen K et al. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. 2016 Cell. Signal. pmid:27634386
Bae YC et al. Effects of sphingosylphosphorylcholine on cryopreserved fat tissue graft survival. 2016 Mol Med Rep pmid:27572900
Wirrig C et al. Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells. 2016 Biochem. Pharmacol. pmid:27402344
Vanier MT et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review. 2016 Mol. Genet. Metab. pmid:27339554
Aksu F et al. Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats. 2016 Ren Fail pmid:27309733
Li W et al. Sphingosylphosphorylcholine promotes the differentiation of resident Sca-1 positive cardiac stem cells to cardiomyocytes through lipid raft/JNK/STAT3 and β-catenin signaling pathways. 2016 Biochim. Biophys. Acta pmid:27066979
Lee EJ et al. Epithelial membrane protein 2 regulates sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization: Changes of PP2A expression by interaction with alpha4 and caveolin-1 in lung cancer cells. 2016 Biochim. Biophys. Acta pmid:26876307
Park MK et al. Novel effects of FTY720 on perinuclear reorganization of keratin network induced by sphingosylphosphorylcholine: Involvement of protein phosphatase 2A and G-protein-coupled receptor-12. 2016 Eur. J. Pharmacol. pmid:26872988
El-Najjar N et al. Increased Levels of Sphingosylphosphorylcholine (SPC) in Plasma of Metabolic Syndrome Patients. 2015 PLoS ONE pmid:26466367
Yokota K and Ogino T Phase separation in lipid bilayer membranes induced by intermixing at a boundary of two phases with different components. 2015 Chem. Phys. Lipids pmid:26363303
Tobo A et al. Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses. 2015 PLoS ONE pmid:26070068
Hyder CL et al. Sphingolipids inhibit vimentin-dependent cell migration. 2015 J. Cell. Sci. pmid:25908861
Yue HW et al. Sphingosylphosphorylcholine protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy. 2015 Biochim. Biophys. Acta pmid:25871970
Aksu B et al. Effects of sphingosylphosphorylcholine against oxidative stress and acute lung ınjury ınduced by pulmonary contusion in rats. 2015 J. Pediatr. Surg. pmid:25840069
Shaifta Y et al. Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species. 2015 Cardiovasc. Res. pmid:25661082
Shirao S et al. A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts. 2015 J. Cereb. Blood Flow Metab. pmid:25605290
Welford RW et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. 2014 PLoS ONE pmid:25479233
Yue H et al. Inhibition of autophagy promoted sphingosylphosphorylcholine induced cell death in non-small cell lung cancer cells. 2014 Biochem. Biophys. Res. Commun. pmid:25285628
Wang XQ et al. Sphingosylphosphorylcholine induces α-smooth muscle actin expression in human lung fibroblasts and fibroblast-mediated gel contraction via S1P2 receptor and Rho/Rho-kinase pathway. 2014 Prostaglandins Other Lipid Mediat. pmid:24614064
Chuang WL et al. Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients. 2014 Mol. Genet. Metab. pmid:24418695
Davenport AP et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. 2013 Pharmacol. Rev. pmid:23686350
Sugiyama E et al. Effects of various lysosphingolipids on cell growth, morphology and lipid composition in three neuroblastoma cell lines. 1990 Biochem. Biophys. Res. Commun. pmid:2357225
Sakamoto S et al. Investigation of interfacial behavior of glycyrrhizin with a lipid raft model via a Langmuir monolayer study. 2013 Biochim. Biophys. Acta pmid:23333324
Yoneda H et al. A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study. 2014 World Neurosurg pmid:23032083
Yang CR et al. The G protein coupled receptor 3 is involved in cAMP and cGMP signaling and maintenance of meiotic arrest in porcine oocytes. 2012 PLoS ONE pmid:22685609
Jeong HS et al. PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation. 2012 Mol. Cell. Biochem. pmid:22544520
Russell JL et al. Regulated expression of pH sensing G Protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. 2012 ACS Chem. Biol. pmid:22462679
Busch T et al. Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells. 2012 J. Cell. Sci. pmid:22344252
Ge D et al. Human vascular endothelial cells reduce sphingosylphosphorylcholine-induced smooth muscle cell contraction in co-culture system through integrin β4 and Fyn. 2012 Acta Pharmacol. Sin. pmid:22139003
Kim KH et al. Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells. 2012 Exp. Mol. Med. pmid:22127053
Xu D et al. Sphingosylphosphorylcholine induces stress fiber formation via activation of Fyn-RhoA-ROCK signaling pathway in fibroblasts. 2012 Cell. Signal. pmid:21951603
Park MK et al. Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells. 2011 Biochim. Biophys. Acta pmid:21840417
Jeong HS et al. Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects. 2011 J. Biomed. Sci. pmid:21838918
Andoh T et al. Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. 2011 Exp. Dermatol. pmid:21824199
Yi H et al. Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells. 2011 Neurochem. Res. pmid:21674237
Ghosh TK et al. Intracellular calcium release mediated by sphingosine derivatives generated in cells. 1990 Science pmid:2163543
Lee HY et al. Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells. 2011 J. Immunol. pmid:21368227
Ge D et al. Regulation of apoptosis and autophagy by sphingosylphosphorylcholine in vascular endothelial cells. 2011 J. Cell. Physiol. pmid:21302284
Herzog C et al. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. 2010 Mediators Inflamm. pmid:21274265
Yamamoto H et al. Sphingosylphosphorylcholine and lysosulfatide have inverse regulatory functions in monocytic cell differentiation into macrophages. 2011 Arch. Biochem. Biophys. pmid:21081108
Kovacs E et al. Regulation of ryanodine receptors by sphingosylphosphorylcholine: involvement of both calmodulin-dependent and -independent mechanisms. 2010 Biochem. Biophys. Res. Commun. pmid:20851108
Horii K et al. Development of a sphingosylphosphorylcholine detection system using RNA aptamers. 2010 Molecules pmid:20729797
Kudo R and Hatake K [Effect of ethanol on sphingosylphosphorylcholine (SPC)-induced vasoconstriction in rat artery]. 2010 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:20681251
Wirrig C et al. Sphingosylphosphorylcholine is a proinflammatory mediator in cerebral arteries. 2011 J. Cereb. Blood Flow Metab. pmid:20551970
Dressler KA et al. Sphingomyelin synthesis is involved in adherence during macrophage differentiation of HL-60 cells. 1991 J. Biol. Chem. pmid:2050663
Kim DS et al. Sphingosylphosphorylcholine inhibits melanin synthesis via pertussis toxin-sensitive MITF degradation. 2010 J. Pharm. Pharmacol. pmid:20487197
Choi H et al. Sphingosylphosphorylcholine down-regulates filaggrin gene transcription through NOX5-based NADPH oxidase and cyclooxygenase-2 in human keratinocytes. 2010 Biochem. Pharmacol. pmid:20230798
Sundh M et al. Influence of phase separating lipids on supported lipid bilayer formation at SiO2 surfaces. 2010 Phys Chem Chem Phys pmid:20023823